⚡️ Based on the analysts' long-term price targets, what is the recommended investment horizon for this stock?

**Analysts' long-term price targets suggest a recommended investment horizon of at least 3-5 years for Incannex Healthcare (IXHL)**: 1. **2025 Price Target**: The average price target for 2025 is $4.3834, with a high of $4.9768 and a low of $3.79. This target is significantly above the current trading price, indicating potential for growth in the short to medium term. 2. **2026 Price Forecast**: The projected average price for 2026 is $33.59, with a high of $5.4291 and a low of $0.1263. This suggests that the stock could experience substantial appreciation within the next year. 3. **Long-term Outlook**: The price forecasts for 2027 and beyond indicate even more significant increases, with prices predicted to reach as high as $55.75 by 2029 and $21.83 by 2030. These long-term targets imply a strong potential for investor returns. Given these analyst expectations, it appears that IXHL is a strong buy candidate for investors with a medium to long-term investment horizon. However, it's important to note that these targets are based on analysts' opinions and should be considered in the context of the company's financials, market conditions, and clinical development pipeline.